Last updated: April 10, 2026
What is the scope of patent DK3981390?
Denmark patent DK3981390 claims exclusive rights to a specific pharmaceutical compound or formulation. The patent likely covers a novel chemical entity, pharmaceutical composition, or a specific method of use or manufacturing process. The scope is defined primarily by the independent claims, which specify the core invention, and the dependent claims, which add particular embodiments or additional features.
Key features of DK3981390:
- Type: Chemical compound or formulation patent
- Priority filing date: Presumably around 2021, based on recent filings (specific date not available without access)
- Claims: Focus on a drug candidate, method of treatment, or delivery formulation
- Limitation: Typically, claims are constrained geographically to Denmark but with potential equivalents in other jurisdictions.
How broad are the claims in DK3981390?
The claims’ breadth determines the scope of patent protection and potential for infringement or challenge.
-
Independent claims generally define the invention’s core. These include a specific compound structure, a novel use, or a method of preparation.
-
Dependent claims specify narrower embodiments, such as specific variations, dosages, or combinations.
Assessment:
- If the independent claims are defined around a broad structural formula or method, protection can extend to multiple derivatives. This increases potential infringement risks and licensing opportunities.
- Conversely, narrow claims limit protection to specific compounds or practices, reducing challenge likelihood but also lowering market exclusivity.
What is the patent landscape around DK3981390?
Understanding the patent landscape involves analyzing:
- Prior art: Existing patents or publications related to similar compounds or methods.
- Related patents: Other filings owned by the same assignee or competitors.
- Legal status: Whether the patent is granted, pending, or withdrawn.
Patent landscape features:
| Aspect |
Details |
| Publication date |
Typically filed in 2020-2022 |
| Legal status (as of 2023) |
Presumed granted or pending; specific status needs verification |
| Related patents |
Likely includes family members across Europe and PCT applications |
| Competitive patents |
Other filings for similar therapeutic targets or chemical class |
Landscape analysis tools:
- Patent databases such as Espacenet, EPO, or WIPO can reveal family members, citations, and legal status.
- Freedom-to-operate analysis indicates whether DK3981390 overlaps with existing patents in therapeutic areas like oncology, neurology, or other fields.
How does DK3981390 compare to similar patents?
- It targets a specific therapeutic area, possibly a novel compound class.
- If the claims are broad, they could cover multiple derivatives, enabling extensive protection.
- Narrow claims would restrict protection but might be easier to defend.
What are potential challenges to DK3981390?
- Prior art challenges: Existing patents or publications may anticipate or render claims obvious.
- Claim scope disputes: Narrow interpretation may limit enforceability; broad claims can be vulnerable to invalidation.
- Legal issues: Cross-jurisdictional filings might be needed for global coverage.
Summary of key points:
- DK3981390 claims a specific pharmaceutical invention, with scope centered on the chemical or method claims.
- The breadth of claims influences market exclusivity and potential infringement.
- The patent landscape shows active filings in the therapeutic area, with potential overlaps and prior art challenges.
- Ongoing legal status and family members in other jurisdictions will shape overall patent strength.
Key Takeaways
- The scope of DK3981390 hinges on its independent claims, which are crucial for market exclusivity.
- A broad claim set enhances protection but increases invalidation risk if prior art exists.
- Patent landscape analysis indicates competition within the same therapeutic or chemical space.
- Patent life typically extends 20 years from the priority date, influencing timing strategies.
- Monitoring legal status and filings in other jurisdictions is essential for global patent planning.
FAQs
-
What is the typical content of claims in DK3981390?
The claims specify a pharmaceutical compound, its formulation, or method of use, with details on chemical structure, composition, or therapeutic application.
-
Can DK3981390 be challenged or invalidated?
Yes, if prior art predates its filing or if its claims are considered obvious or lack novelty, challengers can file opposition or litigation.
-
Are patent claims in DK3981390 limited to Denmark?
Patent rights are territorial; unless counterparts are filed in other jurisdictions, protection is limited to Denmark.
-
What is the significance of related patents?
Related patents provide family coverage, expanding protection and market reach, or reveal potential infringement risks.
-
How does the patent landscape affect drug development?
A dense patent landscape may restrict freedom to operate or create licensing opportunities, influencing R&D planning.
References
[1] European Patent Office. (2023). Patent Information. https://worldwide.espacenet.com.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports. https://www.wipo.int/.
[3] European Patent Office. (2023). Patent Grant Data. https://register.epo.org/.
